Drug
V0116 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses V0116 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Nicotine Patch Safety StudyCompletedPhase 2Pierre Fabre MedicamentNCT01655082Written as V0116 transdermal patch
- Nicotine Patch Bioequivalence StudyCompletedPhase 1Pierre Fabre MedicamentNCT01658202Written as V0116 transdermal patch (Test treatment )
- Nicotine Patch - Multidose Bioequivalence StudyCompletedPhase 1Pierre Fabre MedicamentNCT01658215Written as V0116 transdermal patch (Test treatment )